RT Journal Article
SR Electronic
T1 Hypokalemia in Patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.14.20131169
DO 10.1101/2020.06.14.20131169
A1 Gaetano, Alfano
A1 Annachiara, Ferrari
A1 Francesco, Fontana
A1 Perrone, Rossella
A1 Mori, Giacomo
A1 Elisabetta, Ascione
A1 Riccardo, Magistroni
A1 Giulia, Venturi
A1 Pederzoli, Simone
A1 Margiotta, Gianlulca
A1 Romeo, Marilina
A1 Piccinini, Francesca
A1 Giacomo, Franceschi
A1 Sara, Volpi
A1 Matteo, Faltoni
A1 Giacomo, Ciusa
A1 Erica, Bacca
A1 Marco, Tutone
A1 Alessandro, Raimondi
A1 Marianna, Menozzi
A1 Erica, Franceschini
A1 Gianluca, Cuomo
A1 Gabriella, Orlando
A1 Antonella, Santoro
A1 Di Gaetano, Margherita
A1 Cinzia, Puzzolante
A1 Federica, Carli
A1 Andrea, Bedini
A1 Jovana, Milic
A1 Marianna, Meschiari
A1 Cristina, Mussini
A1 Gianni, Cappelli
A1 Giovanni, Guaraldi
A1 Modena Covid-19 Working Group (MoCo19) includes
A1 Mussini, Cristina
A1 Guaraldi, Giovanni
A1 Bacca, Erica
A1 Bedini, Andrea
A1 Borghi, Vanni
A1 Burastero, Giulia
A1 Carli, Federica
A1 Ciusa, Giacomo
A1 Corradi, Luca
A1 Cuomo, Gianluca
A1 Digaetano, Margherita
A1 Dolci, Giovanni
A1 Faltoni, Matteo
A1 Fantini, Riccardo
A1 Franceschi, Giacomo
A1 Franceschini, Erica
A1 Iadisernia, Vittorio
A1 Larné, Damiano
A1 Menozzi, Marianna
A1 Meschiari, Marianna
A1 Milic, Jovana
A1 Orlando, Gabriella
A1 Pellegrino, Francesco
A1 Raimondi, Alessandro
A1 Rogati, Carlotta
A1 Santoro, Antonella
A1 Tonelli, Roberto
A1 Tutone, Marco
A1 Volpi, Sara
A1 Yaacoub, Dina
A1 Cappelli, Gianni
A1 Magistroni, Riccardo
A1 Alfano, Gaetano
A1 Fontana, Francesco
A1 Marco, Ballestri
A1 Mori, Giacomo
A1 Pulizzi, Roberto
A1 Ascione, Elisabetta
A1 Leonelli, Marco
A1 Facchini, Francesca
A1 Damiano, Francesca
A1 Girardis, Massimo
A1 Andreotti, Alberto
A1 Biagioni, Emanuela
A1 Bondi, Filippo
A1 Busani, Stefano
A1 Chierego, Giovanni
A1 Scotti, Marzia
A1 Serio, Lucia
A1 Cossarizza, Andrea
A1 Bellinazzi, Caterina
A1 Borella, Rebecca
A1 De Biasi, Sara
A1 De Gaetano, Anna
A1 Fidanza, Lucia
A1 Gibellini, Lara
A1 Iannone, Anna
A1 Tartaro, Domenico Lo
A1 Mattioli, Marco
A1 Nasi, Milena
A1 Paolini, Annamaria
A1 Pinti, Marcello
YR 2020
UL http://medrxiv.org/content/early/2020/06/16/2020.06.14.20131169.abstract
AB Patients with COVID-19 may experience multiple conditions (e.g., fever, hyperventilation, anorexia, gastroenteritis, acid-base disorder) that may cause electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder that may increase the susceptibility to various kinds of arrhythmia. This study aimed to estimate prevalence, risk factors and outcome of hypokalemia in a cohort of non-critically ill patients. A retrospective analysis was conducted on 290 hospitalized patients with confirmed COVID-19 infection at the tertiary teaching hospital of Modena, Italy.Hypokalemia (<3.5 mEq/L) was detected in 119 patients (41%). The decrease of serum potassium level was of mild entity (3-3.4 mEq/L) and occurred in association with hypocalcemia (P=0.001) and lower level of serum magnesium (P=0.028) compared to normokaliemic patients. Urine K: creatinine ratio, measured in a small subset of patients (n=45; 36.1%), showed an increase of urinary potassium excretion in the majority of the cases (95.5%). Causes of kaliuria were diuretic therapy (53.4%) and corticosteroids (23.3%). In the remaining patients, urinary potassium loss was associated with normal serum magnesium, low sodium excretion (FENa< 1%) and metabolic alkalosis. Risk factors for hypokalemia were female gender (P=0.002; HR 0.41, 95%CI 0.23-0.73) and diuretic therapy (P=0.027; HR 1.94, 95%CI 1.08-3.48). Hypokalemia, adjusted for sex, age and SOFA score, resulted not associated with ICU admission (P=0.131, 95% CI 0.228-1.212) and in-hospital mortality (P=0.474; 95% CI 0,170-1,324) in our cohort of patients.Hypokalemia is a frequent disorder in COVID-19 patients and urinary potassium loss may be the main cause of hypokalemia. The disorder was mild in the majority of the patients and was unrelated to poor outcomes. Nevertheless, hypokalemic patients required potassium supplements to dampen the risk of arrhythmias.Competing Interest StatementThe authors have declared no competing interest.Funding StatementIt was not fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the Ethical CommitteeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request